A detailed history of North Rock Partners, LLC transactions in Natera, Inc. stock. As of the latest transaction made, North Rock Partners, LLC holds 4,092 shares of NTRA stock, worth $835,913. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,092
Previous 1,394 193.54%
Holding current value
$835,913
Previous $235,000 180.0%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$133.66 - $181.11 $360,614 - $488,634
2,698 Added 193.54%
4,092 $658,000
Q2 2025

Nov 14, 2025

SELL
$132.23 - $171.87 $356,756 - $463,705
-2,698 Reduced 65.93%
1,394 $235,000
Q2 2025

Jul 25, 2025

BUY
$132.23 - $171.87 $184,328 - $239,586
1,394 New
1,394 $235,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $19.8B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track North Rock Partners, LLC Portfolio

Follow North Rock Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Rock Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Rock Partners, LLC with notifications on news.